IBDEI14H ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18747,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,18747,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,18747,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,18748,0)
 ;;=N18.2^^94^912^14
 ;;^UTILITY(U,$J,358.3,18748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18748,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,18748,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,18748,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,18749,0)
 ;;=N18.3^^94^912^15
 ;;^UTILITY(U,$J,358.3,18749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18749,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,18749,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,18749,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,18750,0)
 ;;=N18.4^^94^912^16
 ;;^UTILITY(U,$J,358.3,18750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18750,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,18750,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,18750,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,18751,0)
 ;;=N18.5^^94^912^17
 ;;^UTILITY(U,$J,358.3,18751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18751,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,18751,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,18751,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,18752,0)
 ;;=Q61.3^^94^912^80
 ;;^UTILITY(U,$J,358.3,18752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18752,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,18752,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,18752,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,18753,0)
 ;;=N20.1^^94^912^9
 ;;^UTILITY(U,$J,358.3,18753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18753,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,18753,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,18753,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,18754,0)
 ;;=N18.9^^94^912^18
 ;;^UTILITY(U,$J,358.3,18754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18754,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,18754,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,18754,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,18755,0)
 ;;=N18.6^^94^912^28
 ;;^UTILITY(U,$J,358.3,18755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18755,1,3,0)
 ;;=3^End Stage Renal Disease (ESRD)
 ;;^UTILITY(U,$J,358.3,18755,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,18755,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,18756,0)
 ;;=N52.9^^94^912^44
 ;;^UTILITY(U,$J,358.3,18756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18756,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,18756,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,18756,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,18757,0)
 ;;=N32.81^^94^912^75
 ;;^UTILITY(U,$J,358.3,18757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18757,1,3,0)
 ;;=3^Overactive Bladder
 ;;^UTILITY(U,$J,358.3,18757,1,4,0)
 ;;=4^N32.81
 ;;^UTILITY(U,$J,358.3,18757,2)
 ;;=^5015652
 ;;^UTILITY(U,$J,358.3,18758,0)
 ;;=Q61.2^^94^912^79
 ;;^UTILITY(U,$J,358.3,18758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18758,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,18758,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,18758,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,18759,0)
 ;;=N41.1^^94^912^83
 ;;^UTILITY(U,$J,358.3,18759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18759,1,3,0)
 ;;=3^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,18759,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,18759,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,18760,0)
 ;;=N11.9^^94^912^91
 ;;^UTILITY(U,$J,358.3,18760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18760,1,3,0)
 ;;=3^Pyelonephritis,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,18760,1,4,0)
 ;;=4^N11.9
